Nazareno, Melodia L.
HRN: 22-92-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2023
CEFTAZIDIME 1GM (VIAL)
06/07/2023
06/14/2023
IVT
1gm
Q8
Cap Mr, Ptb Ongoing Treatment
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes